| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Review Article |
1 From the Department of Molecular and Cellular Biology, University of California, Berkeley (BNA, IE-S, and EAS), and the Children's Hospital Oakland Research Institute, Oakland, CA (BNA and IE-S).
As many as one-third of mutations in a gene result in the corresponding enzyme having an increased Michaelis constant, or Km, (decreased binding affinity) for a coenzyme, resulting in a lower rate of reaction. About 50 human genetic dis-eases due to defective enzymes can be remedied or ameliorated by the administration of high doses of the vitamin component of the corresponding coenzyme, which at least partially restores enzymatic activity. Several single-nucleotide polymorphisms, in which the variant amino acid reduces coenzyme binding and thus enzymatic activity, are likely to be remediable by raising cellular concentrations of the cofactor through high-dose vitamin therapy. Some examples include the alanine-to-valine substitution at codon 222 (Ala222
Val) [DNA: C-to-T substitution at nucleo-tide 677 (677CT)] in methylenetetrahydrofolate reductase (NADPH) and the cofactor FAD (in relation to cardiovascular disease, migraines, and rages), the Pro187Ser (DNA: 609CT) mutation in NAD(P):quinone oxidoreductase 1 [NAD(P)H dehy-drogenase (quinone)] and FAD (in relation to cancer), the Ala44Gly (DNA: 131CG) mutation in glucose-6-phosphate 1-dehydrogenase and NADP (in relation to favism and hemolytic anemia), and the Glu487Lys mutation (present in one-half of Asians) in aldehyde dehydrogenase (NAD + ) and NAD (in relation to alcohol intolerance, Alzheimer disease, and cancer).
Key Words: Genetic disease • therapeutic vitamin use • binding defect • favism • alcohol intolerance • autism • migraine headaches • single nucleotide polymorphisms • enzyme mutations • review
This article has been cited by other articles:
|
|
 |
|
  B. J. Henriques, J. V. Rodrigues, R. K. Olsen, P. Bross, and C. M. Gomes Role of Flavinylation in a Mild Variant of Multiple Acyl-CoA Dehydrogenation Deficiency: A MOLECULAR RATIONALE FOR THE EFFECTS OF RIBOFLAVIN SUPPLEMENTATION J. Biol. Chem., February 13, 2009; 284(7): 4222 - 4229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rowbotham and P. Clayton An unsuitable and degraded diet? Part three: Victorian consumption patterns and their health benefits J R Soc Med, September 1, 2008; 101(9): 454 - 462. [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Marini, J. Gin, J. Ziegle, K. H. Keho, D. Ginzinger, D. A. Gilbert, and J. Rine The prevalence of folate-remedial MTHFR enzyme variants in humans PNAS, June 10, 2008; 105(23): 8055 - 8060. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Mysterud Niko Tinbergen's life and work: a new approach to biology Social Science Information, September 1, 2007; 46(3): 543 - 553. [Abstract] [PDF]
|
|
|
|
 |
|
 A. G. Tsamaloukas Vitamins and Thrombosis (VITRO) study--homocysteine lowering with B vitamins Blood, June 15, 2007; 109(12): 5520 - 5521. [Full Text] [PDF]
|
|
|
|
|
|
B. N. Ames Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage PNAS, November 21, 2006; 103(47): 17589 - 17594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Solomon Cobalamin-responsive disorders in the ambulatory care setting: unreliability of cobalamin, methylmalonic acid, and homocysteine testing Blood, February 1, 2005; 105(3): 978 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. N. Ames Supplements and Tuning Up Metabolism J. Nutr., November 1, 2004; 134(11): 3164S - 3168S. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kaput and R. L. Rodriguez Nutritional genomics: the next frontier in the postgenomic era Physiol Genomics, January 15, 2004; 16(2): 166 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kimura, K. Umegaki, M. Higuchi, P. Thomas, and M. Fenech Methylenetetrahydrofolate Reductase C677T Polymorphism, Folic Acid and Riboflavin Are Important Determinants of Genome Stability in Cultured Human Lymphocytes J. Nutr., January 1, 2004; 134(1): 48 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Erlandsen, M. G. Patch, A. Gamez, M. Straub, and R. C. Stevens Structural Studies on Phenylalanine Hydroxylase and Implications Toward Understanding and Treating Phenylketonuria Pediatrics, December 1, 2003; 112(6): 1557 - 1565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Wilcken, F Bamforth, Z Li, H Zhu, A Ritvanen, M Redlund, C Stoll, Y Alembik, B Dott, A E Czeizel, et al. Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide J. Med. Genet., August 1, 2003; 40(8): 619 - 625. [Full Text]
|
|
|
|
|
|
B. N. Ames The Metabolic Tune-Up: Metabolic Harmony and Disease Prevention J. Nutr., May 1, 2003; 133(5): 1544S - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. N. Ames An Enthusiasm for Metabolism J. Biol. Chem., February 7, 2003; 278(7): 4369 - 4380. [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Muntau, W. Roschinger, M. Habich, H. Demmelmair, B. Hoffmann, C. P. Sommerhoff, and A. A. Roscher Tetrahydrobiopterin as an Alternative Treatment for Mild Phenylketonuria N. Engl. J. Med., December 26, 2002; 347(26): 2122 - 2132. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
